Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973838 · ClinicalTrials.gov registry record · NA
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
A NA study of Substance-Related Disorders and Treatment Adherence, sponsored by University of Maryland, College Park.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 4
- Study locations
NCT05973838: Recruiting NA study of Substance-Related Disorders and Treatment Adherence, sponsored by University of Maryland, College Park.
NCT05973838 is a NA study of Substance-Related Disorders and Treatment Adherence that is actively recruiting participants, run by University of Maryland, College Park. The registered enrollment target is 180 participants, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973838, a NA study of Substance-Related Disorders and Treatment Adherence, is actively recruiting participants, sponsored by University of Maryland, College Park.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
Primary Outcome
Polysubstance use will be assessed using urinalysis. Urine samples are collected at each visit and sent out for toxicological analysis using a customized panel composed of 40 analytes, including both qualitative and quantitative results for opioids, stimulants, benzodiazepines, alcohol, marijuana, hallucinogens, methadone, buprenorphine and norbuprenorphine.
Conditions Studied
Interventions
- BEHAVIORAL Peer-Delivered Behavioral Activation ("Peer Activate")
Study Locations (4)
Maryland
- University of Maryland Baltimore (UMD Drug Treatment Center) - Baltimore
- University of Maryland, College Park - College Park
- Caroline County Behavioral Health - Denton
District of Columbia
- HIPS Clinic - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
What NCT05973838 shows while recruiting
NCT05973838 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (88% lower).
The record links to 5 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Peer-Delivered Behavioral Activation ("Peer Activate") is the first listed.
NCT05973838 reports a single indexed study location in Maryland, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05973838 about?
NCT05973838 is a clinical study titled "Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention". The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention...
What is the current status of trial NCT05973838?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-06-15. Estimated completion is 2027-09-01.
What conditions does trial NCT05973838 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Treatment Adherence, Retention in Care, Opioid Medication Assisted Treatment, Polysubstance Addiction.
What interventions are being tested in trial NCT05973838?
The interventions under investigation include: Peer-Delivered Behavioral Activation ("Peer Activate") (BEHAVIORAL).
Who is sponsoring clinical trial NCT05973838?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973838 being conducted?
This trial has 4 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05973838's enrollment target sits among peer trials
180 26th of 58 higher than 33 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI